428 related articles for article (PubMed ID: 28322746)
41. ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production.
Antonello P; Pizzagalli DU; Foglierini M; Melgrati S; Radice E; Thelen S; Thelen M
Front Immunol; 2022; 13():1067885. PubMed ID: 36713377
[TBL] [Abstract][Full Text] [Related]
42. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
Sadir R; Imberty A; Baleux F; Lortat-Jacob H
J Biol Chem; 2004 Oct; 279(42):43854-60. PubMed ID: 15292258
[TBL] [Abstract][Full Text] [Related]
43. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
[TBL] [Abstract][Full Text] [Related]
44. Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.
Proost P; Struyf S; Schols D; Opdenakker G; Sozzani S; Allavena P; Mantovani A; Augustyns K; Bal G; Haemers A; Lambeir AM; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 1999 Feb; 274(7):3988-93. PubMed ID: 9933589
[TBL] [Abstract][Full Text] [Related]
45. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
Ohtsuki T; Hosono O; Kobayashi H; Munakata Y; Souta A; Shioda T; Morimoto C
FEBS Lett; 1998 Jul; 431(2):236-40. PubMed ID: 9708910
[TBL] [Abstract][Full Text] [Related]
46. The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.
Puchert M; Engele J
Cell Tissue Res; 2014 Feb; 355(2):239-53. PubMed ID: 24292718
[TBL] [Abstract][Full Text] [Related]
47. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
[TBL] [Abstract][Full Text] [Related]
48. Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
Brunn A; Utermöhlen O; Mihelcic M; Sánchez-Ruiz M; Carstov M; Blau T; Ustinova I; Penfold M; Montesinos-Rongen M; Deckert M
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):772-87. PubMed ID: 23452257
[TBL] [Abstract][Full Text] [Related]
49. Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation.
Kobayashi K; Sato K; Kida T; Omori K; Hori M; Ozaki H; Murata T
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1716-22. PubMed ID: 24925969
[TBL] [Abstract][Full Text] [Related]
50. Reduced CD26 expression is associated with improved cardiac function after acute myocardial infarction: insights from the REPERATOR study.
Post S; van den Broek AJ; Rensing BJ; Pasterkamp G; Goumans MJ; Doevendans PA
J Mol Cell Cardiol; 2012 Dec; 53(6):899-905. PubMed ID: 22982114
[TBL] [Abstract][Full Text] [Related]
51. Roles of chemokine CXCL12 and its receptors in ischemic stroke.
Wang Y; Huang J; Li Y; Yang GY
Curr Drug Targets; 2012 Feb; 13(2):166-72. PubMed ID: 22204316
[TBL] [Abstract][Full Text] [Related]
52. Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity.
Dillemans L; Yu K; De Zutter A; Noppen S; Gouwy M; Berghmans N; Verhallen L; De Bondt M; Vanbrabant L; Brusselmans S; Martens E; Schols D; Verschueren P; Rosenkilde MM; Marques PE; Struyf S; Proost P
Cell Commun Signal; 2024 Feb; 22(1):94. PubMed ID: 38308278
[TBL] [Abstract][Full Text] [Related]
53. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
[TBL] [Abstract][Full Text] [Related]
54. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
55. Biased antagonism of CXCR4 avoids antagonist tolerance.
Hitchinson B; Eby JM; Gao X; Guite-Vinet F; Ziarek JJ; Abdelkarim H; Lee Y; Okamoto Y; Shikano S; Majetschak M; Heveker N; Volkman BF; Tarasova NI; Gaponenko V
Sci Signal; 2018 Oct; 11(552):. PubMed ID: 30327409
[TBL] [Abstract][Full Text] [Related]
56. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
[TBL] [Abstract][Full Text] [Related]
57. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
Wain CM; Westwick J; Ward SG
Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
[TBL] [Abstract][Full Text] [Related]
58. Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists.
Eby JM; Abdelkarim H; Albee LJ; Tripathi A; Gao X; Volkman BF; Gaponenko V; Majetschak M
Mol Cell Biochem; 2017 Oct; 434(1-2):143-151. PubMed ID: 28455789
[TBL] [Abstract][Full Text] [Related]
59. Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation.
Jackson EK; Mi E; Ritov VB; Gillespie DG
Hypertension; 2018 Oct; 72(4):909-917. PubMed ID: 30354710
[TBL] [Abstract][Full Text] [Related]
60. Chemokine receptor CXCR4: role in gastrointestinal cancer.
Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
